_id
6915ede2bc934aba376b1e53
Ticker
REPL
Name
Replimune Group Inc
Exchange
NASDAQ
Address
500 Unicorn Park Drive, Woburn, MA, United States, 01801
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.replimune.com
Description
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Last Close
10.73
Volume
5320051
Current Price
10.3
Change
-4.00745573159366
Last Updated
2025-12-03T12:51:41.435Z
Image
-
Ipo Date
2018-07-20T00:00:00.000Z
Market Cap
784433344
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.0025000000000000022
Sentiment Sources
2
Rating
4.375
Target Price
12.5714
Strong Buy
3
Buy
5
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
84291000
Operating Income
-84291000
Interest Expense
518000
Pretax Income
-83100000
Net Income
-83100000
Eps
-0.9040886118245934
Dividends Per Share
-
Shares Outstanding
78443334
Income Tax Expense
-
EBITDA
-82040000
Operating Margin
-
Total Other Income Expense Net
1191000
Cash
102298000
Short Term Investments
221346000
Receivables
1806000
Inventories
-
Total Current Assets
333749000
Property Plant Equipment
51997000
Total Assets
389450000
Payables
6404000
Short Term Debt
4051000
Long Term Debt
47206000
Total Liabilities
126114000
Equity
263336000
Depreciation
842000
Change In Working Capital
-6870000
Cash From Operations
-81212000
Capital Expenditures
1343000
Cash From Investing
84169000
Cash From Financing
324000
Net Change In Cash
4923000
PE
-
PB
3.595150001139229
ROE
-31.556642464380108
ROA
-21.337784054435744
FCF
-82555000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
84291000
Quarters > 0 > income Statement > operating Income
-84291000
Quarters > 0 > income Statement > interest Expense
518000
Quarters > 0 > income Statement > pretax Income
-83100000
Quarters > 0 > income Statement > net Income
-83100000
Quarters > 0 > income Statement > eps
-0.9040886118245934
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
91915769
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-82040000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1191000
Quarters > 0 > balance Sheet > cash
102298000
Quarters > 0 > balance Sheet > short Term Investments
221346000
Quarters > 0 > balance Sheet > receivables
1806000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
333749000
Quarters > 0 > balance Sheet > property Plant Equipment
51997000
Quarters > 0 > balance Sheet > total Assets
389450000
Quarters > 0 > balance Sheet > payables
6404000
Quarters > 0 > balance Sheet > short Term Debt
4051000
Quarters > 0 > balance Sheet > long Term Debt
47206000
Quarters > 0 > balance Sheet > total Liabilities
126114000
Quarters > 0 > balance Sheet > equity
263336000
Quarters > 0 > cash Flow > net Income
-83100000
Quarters > 0 > cash Flow > depreciation
842000
Quarters > 0 > cash Flow > change In Working Capital
-6870000
Quarters > 0 > cash Flow > cash From Operations
-81212000
Quarters > 0 > cash Flow > capital Expenditures
1343000
Quarters > 0 > cash Flow > cash From Investing
84169000
Quarters > 0 > cash Flow > cash From Financing
324000
Quarters > 0 > cash Flow > net Change In Cash
4923000
Quarters > 0 > ratios > PE
-0.9040886118245934
Quarters > 0 > ratios > PB
3.595150001139229
Quarters > 0 > ratios > ROE
-31.556642464380108
Quarters > 0 > ratios > ROA
-21.337784054435744
Quarters > 0 > ratios > FCF
-82555000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
1665000
Quarters > 1 > income Statement > gross Profit
-1665000
Quarters > 1 > income Statement > operating Expenses
90422000
Quarters > 1 > income Statement > operating Income
-90422000
Quarters > 1 > income Statement > interest Expense
1996000
Quarters > 1 > income Statement > pretax Income
-86693000
Quarters > 1 > income Statement > net Income
-86693000
Quarters > 1 > income Statement > eps
-0.9472967731100808
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
91516199
Quarters > 1 > income Statement > income Tax Expense
-420000
Quarters > 1 > income Statement > EBITDA
-89429000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
3729000
Quarters > 1 > balance Sheet > cash
97373000
Quarters > 1 > balance Sheet > short Term Investments
305967000
Quarters > 1 > balance Sheet > receivables
1843000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
413371000
Quarters > 1 > balance Sheet > property Plant Equipment
52798000
Quarters > 1 > balance Sheet > total Assets
469507000
Quarters > 1 > balance Sheet > payables
15483000
Quarters > 1 > balance Sheet > short Term Debt
4040000
Quarters > 1 > balance Sheet > long Term Debt
46792000
Quarters > 1 > balance Sheet > total Liabilities
132792000
Quarters > 1 > balance Sheet > equity
336715000
Quarters > 1 > cash Flow > net Income
-86693000
Quarters > 1 > cash Flow > depreciation
873000
Quarters > 1 > cash Flow > change In Working Capital
-417000
Quarters > 1 > cash Flow > cash From Operations
-77016000
Quarters > 1 > cash Flow > capital Expenditures
2740000
Quarters > 1 > cash Flow > cash From Investing
65048000
Quarters > 1 > cash Flow > cash From Financing
-158000
Quarters > 1 > cash Flow > net Change In Cash
-13742000
Quarters > 1 > ratios > PE
-0.9472967731100808
Quarters > 1 > ratios > PB
2.799450127555945
Quarters > 1 > ratios > ROE
-25.74669973122671
Quarters > 1 > ratios > ROA
-18.464687427450496
Quarters > 1 > ratios > FCF
-79756000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1472000
Quarters > 2 > income Statement > cost Of Revenue
848000
Quarters > 2 > income Statement > gross Profit
-848000
Quarters > 2 > income Statement > operating Expenses
79031000
Quarters > 2 > income Statement > operating Income
-79879000
Quarters > 2 > income Statement > interest Expense
1985000
Quarters > 2 > income Statement > pretax Income
-74788000
Quarters > 2 > income Statement > net Income
-74130000
Quarters > 2 > income Statement > eps
-0.9201380269102825
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
80564000
Quarters > 2 > income Statement > income Tax Expense
-658000
Quarters > 2 > income Statement > EBITDA
-71955000
Quarters > 2 > income Statement > operating Margin
-5426.5625
Quarters > 2 > income Statement > total Other Income Expense Net
5091000
Quarters > 2 > balance Sheet > cash
111119000
Quarters > 2 > balance Sheet > short Term Investments
372685000
Quarters > 2 > balance Sheet > receivables
3725000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
495880000
Quarters > 2 > balance Sheet > property Plant Equipment
52545000
Quarters > 2 > balance Sheet > total Assets
551328000
Quarters > 2 > balance Sheet > payables
12463000
Quarters > 2 > balance Sheet > short Term Debt
3983000
Quarters > 2 > balance Sheet > long Term Debt
46377000
Quarters > 2 > balance Sheet > total Liabilities
135485000
Quarters > 2 > balance Sheet > equity
415843000
Quarters > 2 > cash Flow > net Income
-74130000
Quarters > 2 > cash Flow > depreciation
848000
Quarters > 2 > cash Flow > change In Working Capital
13059000
Quarters > 2 > cash Flow > cash From Operations
-53731000
Quarters > 2 > cash Flow > capital Expenditures
1134000
Quarters > 2 > cash Flow > cash From Investing
-7700000
Quarters > 2 > cash Flow > cash From Financing
-132000
Quarters > 2 > cash Flow > net Change In Cash
-61123000
Quarters > 2 > ratios > PE
-0.9201380269102825
Quarters > 2 > ratios > PB
1.9954867582236568
Quarters > 2 > ratios > ROE
-17.826439305218557
Quarters > 2 > ratios > ROA
-13.445716524464565
Quarters > 2 > ratios > FCF
-54865000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-37.27241847826087
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
1000000
Quarters > 3 > income Statement > gross Profit
-1000000
Quarters > 3 > income Statement > operating Expenses
66019000
Quarters > 3 > income Statement > operating Income
-66019000
Quarters > 3 > income Statement > interest Expense
1978000
Quarters > 3 > income Statement > pretax Income
-65765000
Quarters > 3 > income Statement > net Income
-66340000
Quarters > 3 > income Statement > eps
-0.7945005329405143
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
83499000
Quarters > 3 > income Statement > income Tax Expense
575000
Quarters > 3 > income Statement > EBITDA
-64950000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
254000
Quarters > 3 > balance Sheet > cash
172245000
Quarters > 3 > balance Sheet > short Term Investments
364294000
Quarters > 3 > balance Sheet > receivables
3066000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
547577000
Quarters > 3 > balance Sheet > property Plant Equipment
53151000
Quarters > 3 > balance Sheet > total Assets
603628000
Quarters > 3 > balance Sheet > payables
7188000
Quarters > 3 > balance Sheet > short Term Debt
3943000
Quarters > 3 > balance Sheet > long Term Debt
45960000
Quarters > 3 > balance Sheet > total Liabilities
121254000
Quarters > 3 > balance Sheet > equity
482374000
Quarters > 3 > cash Flow > net Income
-66340000
Quarters > 3 > cash Flow > depreciation
993000
Quarters > 3 > cash Flow > change In Working Capital
3333000
Quarters > 3 > cash Flow > cash From Operations
-50713000
Quarters > 3 > cash Flow > capital Expenditures
1800000
Quarters > 3 > cash Flow > cash From Investing
-46320000
Quarters > 3 > cash Flow > cash From Financing
155930000
Quarters > 3 > cash Flow > net Change In Cash
58746000
Quarters > 3 > ratios > PE
-0.7945005329405143
Quarters > 3 > ratios > PB
1.7829312939752144
Quarters > 3 > ratios > ROE
-13.75281420640416
Quarters > 3 > ratios > ROA
-10.990212514992677
Quarters > 3 > ratios > FCF
-52513000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3502000
Annuals > 0 > income Statement > gross Profit
-3502000
Annuals > 0 > income Statement > operating Expenses
261627000
Annuals > 0 > income Statement > operating Income
-261627000
Annuals > 0 > income Statement > interest Expense
7893000
Annuals > 0 > income Statement > pretax Income
-246829000
Annuals > 0 > income Statement > net Income
-247297000
Annuals > 0 > income Statement > eps
-3.0695720172781886
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
80564000
Annuals > 0 > income Statement > income Tax Expense
468000
Annuals > 0 > income Statement > EBITDA
-253924000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
14798000
Annuals > 0 > balance Sheet > cash
111119000
Annuals > 0 > balance Sheet > short Term Investments
372685000
Annuals > 0 > balance Sheet > receivables
3725000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
495880000
Annuals > 0 > balance Sheet > property Plant Equipment
52545000
Annuals > 0 > balance Sheet > total Assets
551328000
Annuals > 0 > balance Sheet > payables
12463000
Annuals > 0 > balance Sheet > short Term Debt
3983000
Annuals > 0 > balance Sheet > long Term Debt
46377000
Annuals > 0 > balance Sheet > total Liabilities
135485000
Annuals > 0 > balance Sheet > equity
415843000
Annuals > 0 > cash Flow > net Income
-247297000
Annuals > 0 > cash Flow > depreciation
3502000
Annuals > 0 > cash Flow > change In Working Capital
24081000
Annuals > 0 > cash Flow > cash From Operations
-192250000
Annuals > 0 > cash Flow > capital Expenditures
6687000
Annuals > 0 > cash Flow > cash From Investing
-23796000
Annuals > 0 > cash Flow > cash From Financing
252396000
Annuals > 0 > cash Flow > net Change In Cash
36665000
Annuals > 0 > ratios > PE
-3.0695720172781886
Annuals > 0 > ratios > PB
1.9373657846831618
Annuals > 0 > ratios > ROE
-59.46883799895634
Annuals > 0 > ratios > ROA
-44.854786987056706
Annuals > 0 > ratios > FCF
-198937000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
2655000
Annuals > 1 > income Statement > gross Profit
-2655000
Annuals > 1 > income Statement > operating Expenses
234773000
Annuals > 1 > income Statement > operating Income
-234773000
Annuals > 1 > income Statement > interest Expense
6660000
Annuals > 1 > income Statement > pretax Income
-215386000
Annuals > 1 > income Statement > net Income
-215794000
Annuals > 1 > income Statement > eps
-3.241615496638766
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
66569894
Annuals > 1 > income Statement > income Tax Expense
408000
Annuals > 1 > income Statement > EBITDA
-227770000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
19387000
Annuals > 1 > balance Sheet > cash
74457000
Annuals > 1 > balance Sheet > short Term Investments
346211000
Annuals > 1 > balance Sheet > receivables
4922000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
433667000
Annuals > 1 > balance Sheet > property Plant Equipment
52355000
Annuals > 1 > balance Sheet > total Assets
487722000
Annuals > 1 > balance Sheet > payables
2578000
Annuals > 1 > balance Sheet > short Term Debt
3879000
Annuals > 1 > balance Sheet > long Term Debt
44809000
Annuals > 1 > balance Sheet > total Liabilities
113214000
Annuals > 1 > balance Sheet > equity
374508000
Annuals > 1 > cash Flow > net Income
-215794000
Annuals > 1 > cash Flow > depreciation
2655000
Annuals > 1 > cash Flow > change In Working Capital
5483000
Annuals > 1 > cash Flow > cash From Operations
-185467000
Annuals > 1 > cash Flow > capital Expenditures
5662000
Annuals > 1 > cash Flow > cash From Investing
97201000
Annuals > 1 > cash Flow > cash From Financing
16283000
Annuals > 1 > cash Flow > net Change In Cash
-72069000
Annuals > 1 > ratios > PE
-3.241615496638766
Annuals > 1 > ratios > PB
1.7775292917641279
Annuals > 1 > ratios > ROE
-57.620664979119276
Annuals > 1 > ratios > ROA
-44.245287274307906
Annuals > 1 > ratios > FCF
-191129000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
2447000
Annuals > 2 > income Statement > gross Profit
-2447000
Annuals > 2 > income Statement > operating Expenses
177080000
Annuals > 2 > income Statement > operating Income
-177080000
Annuals > 2 > income Statement > interest Expense
4160000
Annuals > 2 > income Statement > pretax Income
-173996000
Annuals > 2 > income Statement > net Income
-174284000
Annuals > 2 > income Statement > eps
-2.9939011915034115
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
58213010
Annuals > 2 > income Statement > income Tax Expense
288000
Annuals > 2 > income Statement > EBITDA
-171719000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
3084000
Annuals > 2 > balance Sheet > cash
146590000
Annuals > 2 > balance Sheet > short Term Investments
436796000
Annuals > 2 > balance Sheet > receivables
2939000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
592603000
Annuals > 2 > balance Sheet > property Plant Equipment
52352000
Annuals > 2 > balance Sheet > total Assets
646591000
Annuals > 2 > balance Sheet > payables
5364000
Annuals > 2 > balance Sheet > short Term Debt
3757000
Annuals > 2 > balance Sheet > long Term Debt
28648000
Annuals > 2 > balance Sheet > total Liabilities
91299000
Annuals > 2 > balance Sheet > equity
555292000
Annuals > 2 > cash Flow > net Income
-174284000
Annuals > 2 > cash Flow > depreciation
2447000
Annuals > 2 > cash Flow > change In Working Capital
15124000
Annuals > 2 > cash Flow > cash From Operations
-128050000
Annuals > 2 > cash Flow > capital Expenditures
2270000
Annuals > 2 > cash Flow > cash From Investing
-142502000
Annuals > 2 > cash Flow > cash From Financing
311303000
Annuals > 2 > cash Flow > net Change In Cash
40642000
Annuals > 2 > ratios > PE
-2.9939011915034115
Annuals > 2 > ratios > PB
1.048331508467617
Annuals > 2 > ratios > ROE
-31.386009522917675
Annuals > 2 > ratios > ROA
-26.95428795018799
Annuals > 2 > ratios > FCF
-130320000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
4575000
Annuals > 3 > income Statement > gross Profit
-4575000
Annuals > 3 > income Statement > operating Expenses
116909000
Annuals > 3 > income Statement > operating Income
-121484000
Annuals > 3 > income Statement > interest Expense
2223000
Annuals > 3 > income Statement > pretax Income
-121206000
Annuals > 3 > income Statement > net Income
-118036000
Annuals > 3 > income Statement > eps
-2.260694703767806
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
52212269
Annuals > 3 > income Statement > income Tax Expense
-3170000
Annuals > 3 > income Statement > EBITDA
-114408000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
278000
Annuals > 3 > balance Sheet > cash
105948000
Annuals > 3 > balance Sheet > short Term Investments
289707000
Annuals > 3 > balance Sheet > receivables
3055000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
403977000
Annuals > 3 > balance Sheet > property Plant Equipment
55579000
Annuals > 3 > balance Sheet > total Assets
461192000
Annuals > 3 > balance Sheet > payables
3732000
Annuals > 3 > balance Sheet > short Term Debt
3632000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
49963000
Annuals > 3 > balance Sheet > equity
411229000
Annuals > 3 > cash Flow > net Income
-118036000
Annuals > 3 > cash Flow > depreciation
2147000
Annuals > 3 > cash Flow > change In Working Capital
7235000
Annuals > 3 > cash Flow > cash From Operations
-82180000
Annuals > 3 > cash Flow > capital Expenditures
2336000
Annuals > 3 > cash Flow > cash From Investing
-1806000
Annuals > 3 > cash Flow > cash From Financing
6598000
Annuals > 3 > cash Flow > net Change In Cash
-76570000
Annuals > 3 > ratios > PE
-2.260694703767806
Annuals > 3 > ratios > PB
1.2696640801110817
Annuals > 3 > ratios > ROE
-28.703228614713456
Annuals > 3 > ratios > ROA
-25.593678988360598
Annuals > 3 > ratios > FCF
-84516000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.9040886118245934
Valuation > metrics > PB
3.595150001139229
Valuation > final Score
44.04849998860771
Valuation > verdict
19.8% Overvalued
Profitability > metrics > ROE
-31.556642464380108
Profitability > metrics > ROA
-24.898951008092908
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.47890907433848773
Risk > metrics > Interest Coverage
-162.72393822393823
Risk > final Score
-591
Risk > verdict
High
Liquidity > metrics > Current Ratio
31.922429459588713
Liquidity > metrics > Quick Ratio
31.922429459588713
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-121
Prev Risks > 1
-101
Prev Risks > 2
-74
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-10T22:26:13.680Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-11
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.6679
Earnings History > 0 > eps Difference
0.6679
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-11
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.9
Earnings History > 1 > eps Estimate
-0.84
Earnings History > 1 > eps Difference
-0.06
Earnings History > 1 > surprise Percent
-7.1429
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.95
Earnings History > 2 > eps Estimate
-0.8
Earnings History > 2 > eps Difference
-0.15
Earnings History > 2 > surprise Percent
-18.75
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-22
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.82
Earnings History > 3 > eps Estimate
-0.69
Earnings History > 3 > eps Difference
-0.13
Earnings History > 3 > surprise Percent
-18.8406
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-12
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.79
Earnings History > 4 > eps Estimate
-0.72
Earnings History > 4 > eps Difference
-0.07
Earnings History > 4 > surprise Percent
-9.7222
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.68
Earnings History > 5 > eps Estimate
-0.74
Earnings History > 5 > eps Difference
0.06
Earnings History > 5 > surprise Percent
8.1081
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.78
Earnings History > 6 > eps Estimate
-0.85
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
8.2353
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-16
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.82
Earnings History > 7 > eps Estimate
-0.79
Earnings History > 7 > eps Difference
-0.03
Earnings History > 7 > surprise Percent
-3.7975
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-08
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.77
Earnings History > 8 > eps Estimate
-0.93
Earnings History > 8 > eps Difference
0.16
Earnings History > 8 > surprise Percent
17.2043
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.9
Earnings History > 9 > eps Estimate
-0.86
Earnings History > 9 > eps Difference
-0.04
Earnings History > 9 > surprise Percent
-4.6512
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-03
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.75
Earnings History > 10 > eps Estimate
-0.84
Earnings History > 10 > eps Difference
0.09
Earnings History > 10 > surprise Percent
10.7143
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-18
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.74
Earnings History > 11 > eps Estimate
-0.67
Earnings History > 11 > eps Difference
-0.07
Earnings History > 11 > surprise Percent
-10.4478
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.69
Earnings History > 12 > eps Estimate
-0.75
Earnings History > 12 > eps Difference
0.06
Earnings History > 12 > surprise Percent
8
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-03
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.79
Earnings History > 13 > eps Estimate
-0.78
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-1.2821
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.78
Earnings History > 14 > eps Estimate
-0.64
Earnings History > 14 > eps Difference
-0.14
Earnings History > 14 > surprise Percent
-21.875
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-19
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.6
Earnings History > 15 > eps Estimate
-0.58
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-3.4483
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-03
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.57
Earnings History > 16 > eps Estimate
-0.58
Earnings History > 16 > eps Difference
0.01
Earnings History > 16 > surprise Percent
1.7241
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-04
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.56
Earnings History > 17 > eps Estimate
-0.54
Earnings History > 17 > eps Difference
-0.02
Earnings History > 17 > surprise Percent
-3.7037
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-06
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.53
Earnings History > 18 > eps Estimate
-0.46
Earnings History > 18 > eps Difference
-0.07
Earnings History > 18 > surprise Percent
-15.2174
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-20
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.41
Earnings History > 19 > eps Estimate
-0.41
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
0
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-04
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.42
Earnings History > 20 > eps Estimate
-0.42
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-05
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.46
Earnings History > 21 > eps Estimate
-0.44
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-4.5455
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-07
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.44
Earnings History > 22 > eps Estimate
-0.46
Earnings History > 22 > eps Difference
0.02
Earnings History > 22 > surprise Percent
4.3478
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-03
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.41
Earnings History > 23 > eps Estimate
-0.45
Earnings History > 23 > eps Difference
0.04
Earnings History > 23 > surprise Percent
8.8889
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-13
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.46
Earnings History > 24 > eps Estimate
-0.36
Earnings History > 24 > eps Difference
-0.1
Earnings History > 24 > surprise Percent
-27.7778
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-11
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.35
Earnings History > 25 > eps Estimate
-0.35
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
0
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-14
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.3
Earnings History > 26 > eps Estimate
-0.32
Earnings History > 26 > eps Difference
0.02
Earnings History > 26 > surprise Percent
6.25
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-06-28
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.15
Earnings History > 27 > eps Estimate
-0.4
Earnings History > 27 > eps Difference
0.25
Earnings History > 27 > surprise Percent
62.5
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-14
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.24
Earnings History > 28 > eps Estimate
-0.24
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
0
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-14
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.26
Earnings History > 29 > eps Estimate
-0.2
Earnings History > 29 > eps Difference
-0.06
Earnings History > 29 > surprise Percent
-30
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-2.02
Earnings History > 30 > eps Estimate
-0.23
Earnings History > 30 > eps Difference
-1.79
Earnings History > 30 > surprise Percent
-778.2609
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-04-11
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.42
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.42
Earnings History > 31 > surprise Percent
-
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$12.5714
Analyst Picks
Strong Buy
3
Buy
5
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 111.55% of the total shares of Replimune Group Inc
1.
Baker Bros Advisors LP(14.1506%)
since
2025/06/30
2.
T. Rowe Price Associates, Inc.(13.8609%)
since
2025/06/30
3.
BlackRock Inc(7.3414%)
since
2025/06/30
4.
Redmile Group, LLC(5.9762%)
since
2025/06/30
5.
US Small-Cap Growth II Equity Comp(5.3991%)
since
2025/06/30
6.
T. Rowe Price New Horizons(5.39%)
since
2025/07/31
7.
FCPM III SERVICES BV(5.0088%)
since
2025/06/30
8.
Vanguard Group Inc(4.4451%)
since
2025/06/30
9.
TANG CAPITAL MANAGEMENT LLC(4.0996%)
since
2025/06/30
10.
State Street Corp(3.1422%)
since
2025/06/30
11.
Boxer Capital Management, LLC(2.833%)
since
2025/06/30
12.
RTW INVESTMENTS, LLC(2.6456%)
since
2025/06/30
13.
Omega Fund Management LLC(2.5305%)
since
2025/06/30
14.
Marshall Wace Asset Management Ltd(2.3913%)
since
2025/06/30
15.
Sofinnova Ventures(2.3144%)
since
2025/06/30
16.
T. Rowe Price Health Sciences(2.2157%)
since
2025/07/31
17.
Vanguard Total Stock Mkt Idx Inv(2.1849%)
since
2025/07/31
18.
Geode Capital Management, LLC(2.0806%)
since
2025/06/30
19.
T. Rowe Price Integrated US Sm Gr Eq(2.0494%)
since
2025/07/31
20.
iShares Russell 2000 ETF(2.0271%)
since
2025/08/31
21.
T. Rowe Price Integrated US SmCapGrEq(1.8987%)
since
2025/06/30
22.
T. Rowe Price New Horizons Tr-A(1.666%)
since
2025/06/30
23.
Dimensional Fund Advisors, Inc.(1.4931%)
since
2025/06/30
24.
Goldman Sachs Group Inc(1.4315%)
since
2025/06/30
25.
Fidelity Select Biotechnology(1.282%)
since
2025/07/31
26.
MPM Oncology Impact Management LP(1.2604%)
since
2025/06/30
27.
SPDR® S&P Biotech ETF(1.2414%)
since
2025/08/31
28.
Wellington Management Company LLP(1.21%)
since
2025/06/30
29.
Morgan Stanley - Brokerage Accounts(1.1808%)
since
2025/06/30
30.
Rosalind Advisors, Inc.(1.153%)
since
2025/06/30
31.
Vanguard Institutional Extnd Mkt Idx Tr(0.9161%)
since
2025/07/31
32.
Fidelity Small Cap Index(0.8468%)
since
2025/06/30
33.
iShares Russell 2000 Value ETF(0.7523%)
since
2025/08/31
34.
iShares Biotechnology ETF(0.4795%)
since
2025/08/31
35.
Fidelity Enhanced Small Cap ETF(0.4763%)
since
2025/08/29
36.
Fidelity Extended Market Index(0.4638%)
since
2025/07/31
37.
Artisan Non-U.S. Small-Mid Growth Comp(0.4514%)
since
2025/06/30
38.
Artisan International Small-Mid Investor(0.4514%)
since
2025/06/30
39.
Schwab US Small-Cap ETF™(0.4099%)
since
2025/08/30
40.
Vanguard Russell 2000 ETF(0.3976%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.6679
Date
2025-09-30
EPS Actual
-0.9
EPS Estimate
-0.84
EPS Difference
-0.06
Surprise Percent
-7.1429%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.